Union Health and Family Welfare minister J.P. Nadda on Tuesday said facilities envisioned for National Cancer Institute (NCI) in Jhajjar will not be shifted to any other medical institute.
"There have been reports in a section of the media regarding the status of NCI. There should be no confusion. Facilities envisioned for the NCI Jhajjar shall be developed there only and shall not be shifted elsewhere," he said.
"NCI Jhajjar is an integral part of the All India Institute of Medical Sciences (AIIMS), New Delhi, and is a specialty tertiary healthcare institute dedicated to cancer care," Nadda noted.
AIIMS Rewari (at village Manethi), announced in the interim budget 2019 will be 22nd AIIMS to come up in the country and the first in Haryana.
"The site for this AIIMS has been finalised at Manethi in Rewari. The institute will be set up under the Pradhan Mantri Swasthya Suraksha Yojana," he said.
--IANS
som/rs/pcj
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app